Table 1.
Cell type | MLCK Inhibition | Stimulating agent | Effect on [Ca2+]cyt | References |
---|---|---|---|---|
Freshly isolated rabbit portal vein myocytes | ML-9 (5 μM), ML-7 (5 μM), MLCK(11-19)amide (5 μM) | NA, GTPγS, OAG | ↘Icat | 43 |
AV25 (10 μM) | No effect on Icat(ATP) | |||
Freshly isolated rabbit mesenteric artery myocytes | WT (20 μM) | AngII | ↘Icat | 122 |
OAG | No effect | |||
Freshly isolated guinea-pig gastric myocytes | ML-7 (3 μM) | CCh | ↘ICCh | 50 |
Voltage | ↘IBa (L-type VOC) | |||
Freshly isolated human monocytes/ macrophages | ML-9 (10-100 μM), WT (1-100 μM), MLCK antisense | TG, CPA | ↘CCE | 44 |
Freshly isolated murine ileal myocytes | ML-7 (5 μM), ML-9 (10 μM) | CCh | ↘ICCh | 42 |
Cultured bovine adrenal glomerulosa cells | WT (10 μM), ML9 (100 μM), KT5926 (100 μM), MS-347a (30 μM) | AngII | ↘Ca2+ entry | 123 |
Iono, TG, KCl | No effect | |||
Cultured porcine aortic endothelial cells | ML-9 (1-100 μM) | BK, TG | ↘CCE | 124,125 |
ML-7 (0.1-30 μM) | 126 | |||
MLCK antisense | 41 | |||
Cultured rat pulmonary artery endothelial cells | ML-9 (100 μM) | TG | ↘CCE | 127 |
Cultured rat pulmonary artery smooth muscle cells | ML-9 (10-100 μM), ML-7 (1-100 μM) | Hypoxia | ↘CCE | 128 |
Cultured human HEK293 cells | ML-9 (100 μM) | TG | ↘CCE; ↘ICRAC |
49 |
MLCK siRNA, WT (20 μM) | No effect | |||
Cultured human HEK293 cells overexpressing TRPC5 | ML-7 (3 μM), MLCK-siRNA | CCh | ↘ICCh | 46 |
Cultured human HEK293 cells overexpressing TRPC5 | ML-9 (3-50 μM), WT (1-10 μM), | CCh, ATP | ↘Ca2+ entry (no effect on Ca2+ release) | 45 |
MLCK dominant negative | ↘ ICRAC | |||
Cultured human HEK293 cells overexpressing TRPC6 | ML-9 (10 μM), ML-7 (10 μM) | CCh | ↘ICCh | 48 |
WT (3 μM), MLCK dominant negative inhibitory peptide | No effect | |||
Cultured rat aortic SMC | ML-7 (10 μM) | VP | No effect | 47 |
Cultured rat aortic cell line A7r5 | MLCK-siRNA | VP | ↘Ca2+ entry | 410 |
Voltage | ↘IBa (L- and T-type VOC) |
Abbreviations: NA: noradrenaline; VP: vasopressin; KCl: physiological solution enriched in K+; TG: thapsigargin; Iono: ionomycin; AngII: angiotensinII; BK: bradykinin; CCh: carbachol; CPA: cyclopiazonic acid; WT: wortmannin; OAG: 1-oleoyl-2-acetyl-sn-glycerol ; ↘ decrease; VOC: voltage-dependent Ca2+ channels; IBa: barium current; ICRAC: calcium-release activated calcium current; Icat: cationic current; CCE: capacitative Ca2+ entry.